TEDCO Fuels Biotech Innovation in Maryland: Key Investments in Two FITCI Client Companies

Published on : Published by : BioBuzz Media

TEDCO Fuels Biotech Innovation in Maryland: Key Investments in Two FITCI Client Companies TEDCO strengthens Maryland’s biotech ecosystem with strategic investments in NEOPATHOLOGY CORP. and Simmbion, LLC, both innovative companies [….]

HULA Therapeutics Wins $250,000 Investment at PABC’s 10th Annual Entrepreneur Spotlight

Published on : Published by : BioBuzz Media

HULA Therapeutics Wins $250,000 Investment at PABC’s 10th Annual Entrepreneur Spotlight HULA Therapeutics, a Philadelphia-based biotech startup, has won a $250,000 investment at the Pennsylvania Biotechnology Center’s 10th Annual Entrepreneur [….]

25 Innovators Share Why TEDCO’s 25 Years Have Made Such a Difference in Maryland

Published on : Published by : Chris Frew

In honor of the 25 years that TEDCO has been supporting the dreams of entrepreneurs across Maryland and building the foundation of our innovation economy, we asked 25 people that TEDCO has impacted over the years what the organization has meant to them.  

Vector BioMed Launches in Maryland with Gene Therapy Industry Veteran at Helm to Address the Vector Supply Bottleneck with End-to-End Solutions Platform

Published on : Published by : Chris Frew

Biomanufacturing Company Vector BioMed Launches with Mission to Provide Access to High-Quality Lentiviral Vectors and Address the Vector Supply Bottleneck
NEWS PROVIDED BY
Vector BioMed
Jan 31, 2023, 07:30 ET
SHARE THIS ARTICLE
First Round Funding Led by Viking Global Investors and Casdin Capital
Boro Dropulić, Ph.D., MBA, named Chief Executive Officer of Vector BioMed
GAITHERSBURG, Md., Jan. 31, 2023 /PRNewswire/ — Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced its launch and first financing round led by Viking Global Investors and Casdin Capital. The funds will support the acceleration of commercial operations to provide rapid access to high-quality lentiviral vectors for pre-clinical development, clinical trials, and commercialization.
In contrast to traditional contract development and manufacturing organizations (CDMOs), Vector BioMed is a solution provider that will provide partners with the capabilities to take their lentiviral vector-based medicinal concepts into the clinic and accelerate their path to commercialization. Vector BioMed will help address the industry’s current vector supply bottleneck by providing lentiviral vectors at scale, while also offering turnkey solutions for vector design and optimization, pre-clinical manufacturing, GMP manufacturing, and other support services.
In conjunction with the funding and launch, co-founder Boro Dropulić, Ph.D., MBA has…